
Speakers will be added as they are confirmed.
SATURDAY, NOVEMBER 14
5:30pm |
Kick-Off Cocktail ReceptionJoin members in the lobby and exhibit area of Heart House to kick off MACCS. This is a separately ticketed event. Tickets sold through registration or via our Square Site. |
7:00pm |
Reception ConcludesAttendees who have signed up for the Monuments by Moonlight tour should go directly to the pick-up point. |
SUNDAY, NOVEMBER 15
7:00am |
Breakfast in the Exhibit Hall |
|
7:55am |
Welcome & Objectives |
|
8:00am |
Rethinking Established Paradigms
Beta-blockers After MI: Are They Still Necessary? GLP-1 Receptor Agonists and Cardiovascular Outcomes: SELECT, SOUL, and Cardiometabolic Medicine Application of AI in advanced Echo imaging and interpretation- debate on boundaries and advantages. |
|
9:00am |
Intervention Cardiology — Where Are We Now?
Tricuspid and Mitral Transcatheter Interventions: TRISCEND II and MATTERHORN Coronary Physiology-guided PCI: Lessons From FAVOR III and Beyond TAVR in Asymptomatic Severe aortic Stenosis: EARLY-TAVR and Its Implications |
|
10:00am |
BREAKGrab a warm beverage and chat with our Exhibitors |
|
10:30am |
Atrial Fibrillation — Evolving Management StrategiesDevice-detected Subclinical AF: When to Anticoagulate? |
|
11:30am |
ACC in Review
Fred Kusumoto, MD, FACCProfessor of Medicine Director of the Heart Rhythm Services Associate Dean of Faculty Affairs Mayo Clinic Jacksonville, FL Member ACC Board of Trustees |
|
11:45am |
LUNCH in the Exhibit AreaVisit Exhibitors & State of Art Technology Showcases in Conference Rooms |
|
1:00pm |
Heart Failure and Cardiomyopathy — New Therapies Across the SpectrumIron Deficiency in Heart Failure: From IRONMAN to INFERRCT Cardiac Myosin Inhibitors for Obstructive HCM: Mavacamten, Aficamten (SEQUOIA-HCM), and MAPLE-HCM ATTR Cardiac Amyloid: HELIOS-B, Acoramidis, and the Expanding Treatment Landscape |
|
2:00pm |
Preventive Cardiology — Novel Therapeutics and Risk ReductionMenopause and CV Risk Cholesterol Review of New Cholesterol Guidelines The Status of Lp(a) Therapy |
|
3:00pm |
ADJOURN |